MapLight Therapeutics Inc. fell 10.6% on Monday, November 2, 2026, on 245,511 shares. No headline about MPLT came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
MapLight Therapeutics Inc. (MPLT:NASDAQ) closed at $6.78 on November 2, 2026, down 10.55% on the day. The stock trades 83.2% below its 52-week high of $40.43 and 0.2% above its 52-week low of $6.77. Over the past year, it lost 58.3%. MapLight Therapeutics Inc. is part of the Health Care sector.
In 252 trading sessions since October 31, 2025, MPLT closed higher on 119 days (47%). Its best day was December 3, 2025 (+31.26%) and its worst was July 27, 2026 (-72.91%). The stock moved 10% or more in a single session 8 times.
MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders. We were founded by globally recognized leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. Our discovery platform holds the potential to fill this void by identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation.
Find more stocks like MPLT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.